Global Neurological Biomarkers Market Size, Status and Forecast 2022

January 2017 | 110 pages | ID: G26A5D08102EN
QYResearch

Abstracts

Notes:

Production, means the output of Neurological Biomarkers

Revenue, means the sales value of Neurological Biomarkers

This report studies the global Neurological Biomarkers market, analyzes and researches the Neurological Biomarkers development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

• QIAGEN
• Myriad RBM
• Proteome Sciences
• Thermo Fisher Scientific
• AbaStar MDx
• Abiant
• Acumen Pharmaceuticals
• Aepodia
• Alseres Pharmaceuticals
• Athena Diagnostics
• Banyan Biomarkers
• Cisbio Bioassays
• Diagenic ASA
• Proteosys
• Psynova Neurotech

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, Neurological Biomarkers can be split into

• Alzheimer's disease
• Parkinson’s disease
• Autism spectrum disorder
• Multiple sclerosis

Market segment by Application, Neurological Biomarkers can be split into

• Genomics
• Proteomics
• Metabolomics
• Imaging

Contents

Global Neurological Biomarkers Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF NEUROLOGICAL BIOMARKERS

1.1 Neurological Biomarkers Market Overview
  1.1.1 Neurological Biomarkers Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Neurological Biomarkers Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Neurological Biomarkers Market by Type
  1.3.1 Alzheimer's disease
  1.3.2 Parkinson’s disease
  1.3.3 Autism spectrum disorder
  1.3.4 Multiple sclerosis
1.4 Neurological Biomarkers Market by End Users/Application
  1.4.1 Genomics
  1.4.2 Proteomics
  1.4.3 Metabolomics
  1.4.4 Imaging

2 GLOBAL NEUROLOGICAL BIOMARKERS COMPETITION ANALYSIS BY PLAYERS

2.1 Neurological Biomarkers Market Size (Value) by Players (2015-2016)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 QIAGEN
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Neurological Biomarkers Revenue (Value) (2011-2016)
  3.1.5 Recent Developments
3.2 Myriad RBM
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Neurological Biomarkers Revenue (Value) (2011-2016)
  3.2.5 Recent Developments
3.3 Proteome Sciences
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Neurological Biomarkers Revenue (Value) (2011-2016)
  3.3.5 Recent Developments
3.4 Thermo Fisher Scientific
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Neurological Biomarkers Revenue (Value) (2011-2016)
  3.4.5 Recent Developments
3.5 AbaStar MDx
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Neurological Biomarkers Revenue (Value) (2011-2016)
  3.5.5 Recent Developments
3.6 Abiant
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Neurological Biomarkers Revenue (Value) (2011-2016)
  3.6.5 Recent Developments
3.7 Acumen Pharmaceuticals
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Neurological Biomarkers Revenue (Value) (2011-2016)
  3.7.5 Recent Developments
3.8 Aepodia
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Neurological Biomarkers Revenue (Value) (2011-2016)
  3.8.5 Recent Developments
3.9 Alseres Pharmaceuticals
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Neurological Biomarkers Revenue (Value) (2011-2016)
  3.9.5 Recent Developments
3.10 Athena Diagnostics
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Neurological Biomarkers Revenue (Value) (2011-2016)
  3.10.5 Recent Developments
3.11 Banyan Biomarkers
3.12 Cisbio Bioassays
3.13 Diagenic ASA
3.14 Proteosys
3.15 Psynova Neurotech

4 GLOBAL NEUROLOGICAL BIOMARKERS MARKET SIZE BY TYPE AND APPLICATION (2011-2016)

4.1 Global Neurological Biomarkers Market Size by Type (2011-2016)
4.2 Global Neurological Biomarkers Market Size by Application (2011-2016)
4.3 Potential Application of Neurological Biomarkers in Future
4.4 Top Consumer/End Users of Neurological Biomarkers

5 UNITED STATES NEUROLOGICAL BIOMARKERS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Neurological Biomarkers Market Size (2011-2016)
5.2 United States Neurological Biomarkers Market Size and Market Share by Players (2015-2016)

6 EU NEUROLOGICAL BIOMARKERS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Neurological Biomarkers Market Size (2011-2016)
6.2 EU Neurological Biomarkers Market Size and Market Share by Players (2015-2016)

7 JAPAN NEUROLOGICAL BIOMARKERS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Neurological Biomarkers Market Size (2011-2016)
7.2 Japan Neurological Biomarkers Market Size and Market Share by Players (2015-2016)

8 CHINA NEUROLOGICAL BIOMARKERS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Neurological Biomarkers Market Size (2011-2016)
8.2 China Neurological Biomarkers Market Size and Market Share by Players (2015-2016)

9 INDIA NEUROLOGICAL BIOMARKERS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Neurological Biomarkers Market Size (2011-2016)
9.2 India Neurological Biomarkers Market Size and Market Share by Players (2015-2016)

10 SOUTHEAST ASIA NEUROLOGICAL BIOMARKERS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Neurological Biomarkers Market Size (2011-2016)
10.2 Southeast Asia Neurological Biomarkers Market Size and Market Share by Players (2015-2016)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2016-2021)

11.1 Global Neurological Biomarkers Market Size (Value) by Regions (2016-2021)
  11.1.1 United States Neurological Biomarkers Revenue and Growth Rate (2016-2021)
  11.1.2 EU Neurological Biomarkers Revenue and Growth Rate (2016-2021)
  11.1.3 Japan Neurological Biomarkers Revenue and Growth Rate (2016-2021)
  11.1.4 China Neurological Biomarkers Revenue and Growth Rate (2016-2021)
  11.1.5 India Neurological Biomarkers Revenue and Growth Rate (2016-2021)
  11.1.6 Southeast Asia Neurological Biomarkers Revenue and Growth Rate (2016-2021)
11.2 Global Neurological Biomarkers Market Size (Value) by Type (2016-2021)
11.3 Global Neurological Biomarkers Market Size by Application (2016-2021)

12 NEUROLOGICAL BIOMARKERS MARKET DYNAMICS

12.1 Neurological Biomarkers Market Opportunities
12.2 Neurological Biomarkers Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Neurological Biomarkers Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Neurological Biomarkers Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Neurological Biomarkers Product Scope
Figure Global Neurological Biomarkers Market Size (2011-2016)
Table Global Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Figure Global Neurological Biomarkers Market Share by Regions in 2015
Figure United States Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Figure EU Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Figure Japan Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Figure China Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Figure India Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Figure Southeast Asia Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Figure Global Neurological Biomarkers Market Share by Type in 2015
Figure Alzheimer's disease Market Size (Value) and Growth Rate (2011-2016)
Figure Parkinson’s disease Market Size (Value) and Growth Rate (2011-2016)
Figure Autism spectrum disorder Market Size (Value) and Growth Rate (2011-2016)
Figure Multiple sclerosis Market Size (Value) and Growth Rate (2011-2016)
Figure Global Neurological Biomarkers Market Share by Application in 2015
Figure Neurological Biomarkers Market Size and Growth Rate in Genomics (2011-2016)
Figure Neurological Biomarkers Market Size and Growth Rate in Proteomics (2011-2016)
Figure Neurological Biomarkers Market Size and Growth Rate in Metabolomics (2011-2016)
Figure Neurological Biomarkers Market Size and Growth Rate in Imaging (2011-2016)
Table Neurological Biomarkers Market Size (Value) by Players (2015-2016)
Figure Neurological Biomarkers Market Size Share by Players in 2015
Figure Neurological Biomarkers Market Size Share by Players in 2016
Table QIAGEN Basic Information List
Table Neurological Biomarkers Business Revenue of QIAGEN (2011-2016)
Figure QIAGEN Neurological Biomarkers Business Revenue Market Share in 2015
Table Myriad RBM Basic Information List
Table Neurological Biomarkers Business Revenue of Myriad RBM (2011-2016)
Figure Myriad RBM Neurological Biomarkers Business Revenue Market Share in 2015
Table Proteome Sciences Basic Information List
Table Neurological Biomarkers Business Revenue of Proteome Sciences (2011-2016)
Figure Proteome Sciences Neurological Biomarkers Business Revenue Market Share in 2015
Table Thermo Fisher Scientific Basic Information List
Table Neurological Biomarkers Business Revenue of Thermo Fisher Scientific (2011-2016)
Figure Thermo Fisher Scientific Neurological Biomarkers Business Revenue Market Share in 2015
Table AbaStar MDx Basic Information List
Table Neurological Biomarkers Business Revenue of AbaStar MDx (2011-2016)
Figure AbaStar MDx Neurological Biomarkers Business Revenue Market Share in 2015
Table Abiant Basic Information List
Table Neurological Biomarkers Business Revenue of Abiant (2011-2016)
Figure Abiant Neurological Biomarkers Business Revenue Market Share in 2015
Table Acumen Pharmaceuticals Basic Information List
Table Neurological Biomarkers Business Revenue of Acumen Pharmaceuticals (2011-2016)
Figure Acumen Pharmaceuticals Neurological Biomarkers Business Revenue Market Share in 2015
Table Aepodia Basic Information List
Table Neurological Biomarkers Business Revenue of Aepodia (2011-2016)
Figure Aepodia Neurological Biomarkers Business Revenue Market Share in 2015
Table Alseres Pharmaceuticals Basic Information List
Table Neurological Biomarkers Business Revenue of Alseres Pharmaceuticals (2011-2016)
Figure Alseres Pharmaceuticals Neurological Biomarkers Business Revenue Market Share in 2015
Table Athena Diagnostics Basic Information List
Table Neurological Biomarkers Business Revenue of Athena Diagnostics (2011-2016)
Figure Athena Diagnostics Neurological Biomarkers Business Revenue Market Share in 2015
Table Banyan Biomarkers Basic Information List
Table Neurological Biomarkers Business Revenue of Banyan Biomarkers (2011-2016)
Figure Banyan Biomarkers Neurological Biomarkers Business Revenue Market Share in 2015
Table Cisbio Bioassays Basic Information List
Table Neurological Biomarkers Business Revenue of Cisbio Bioassays (2011-2016)
Figure Cisbio Bioassays Neurological Biomarkers Business Revenue Market Share in 2015
Table Diagenic ASA Basic Information List
Table Neurological Biomarkers Business Revenue of Diagenic ASA (2011-2016)
Figure Diagenic ASA Neurological Biomarkers Business Revenue Market Share in 2015
Table Proteosys Basic Information List
Table Neurological Biomarkers Business Revenue of Proteosys (2011-2016)
Figure Proteosys Neurological Biomarkers Business Revenue Market Share in 2015
Table Psynova Neurotech Basic Information List
Table Neurological Biomarkers Business Revenue of Psynova Neurotech (2011-2016)
Figure Psynova Neurotech Neurological Biomarkers Business Revenue Market Share in 2015
Table Global Neurological Biomarkers Market Size by Type (2011-2016)
Figure Global Neurological Biomarkers Market Size Share by Type in 2011
Figure Global Neurological Biomarkers Market Size Share by Type in 2012
Figure Global Neurological Biomarkers Market Size Share by Type in 2013
Figure Global Neurological Biomarkers Market Size Share by Type in 2014
Figure Global Neurological Biomarkers Market Size Share by Type in 2015
Figure Global Neurological Biomarkers Market Size Share by Type in 2016
Table Global Neurological Biomarkers Market Size by Application (2011-2016)
Figure Global Neurological Biomarkers Market Size by Application in 2011
Figure Global Neurological Biomarkers Market Size by Application in 2012
Figure Global Neurological Biomarkers Market Size by Application in 2013
Figure Global Neurological Biomarkers Market Size by Application in 2014
Figure Global Neurological Biomarkers Market Size by Application in 2015
Figure Global Neurological Biomarkers Market Size by Application in 2016
Table Top Consumer/End Users of Neurological Biomarkers
Figure United States Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Table United States Neurological Biomarkers Market Size by Players (2011-2016)
Figure United States Neurological Biomarkers Market Size Share by Players in 2015
Figure United States Neurological Biomarkers Market Size Share by Players in 2016
Figure EU Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Table EU Neurological Biomarkers Market Size by Players (2011-2016)
Figure EU Neurological Biomarkers Market Size Share by Players in 2015
Figure EU Neurological Biomarkers Market Size Share by Players in 2016
Figure Japan Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Table Japan Neurological Biomarkers Market Size by Players (2011-2016)
Figure Japan Neurological Biomarkers Market Size Share by Players in 2015
Figure Japan Neurological Biomarkers Market Size Share by Players in 2016
Figure China Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Table China Neurological Biomarkers Market Size by Players (2011-2016)
Figure China Neurological Biomarkers Market Size Share by Players in 2015
Figure China Neurological Biomarkers Market Size Share by Players in 2016
Figure India Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Table India Neurological Biomarkers Market Size by Players (2011-2016)
Figure India Neurological Biomarkers Market Size Share by Players in 2015
Figure India Neurological Biomarkers Market Size Share by Players in 2016
Figure Southeast Asia Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Table Southeast Asia Neurological Biomarkers Market Size by Players (2011-2016)
Figure Southeast Asia Neurological Biomarkers Market Size Share by Players in 2015
Figure Southeast Asia Neurological Biomarkers Market Size Share by Players in 2016
Figure Global Neurological Biomarkers Market Size (Value) by Regions (2016-2021)
Table Global Neurological Biomarkers Market Size by Regions (2016-2021)
Figure Global Neurological Biomarkers Market Size Share by Regions in 2017
Figure Global Neurological Biomarkers Market Size Share by Regions in 2021
Figure United States Neurological Biomarkers Revenue and Growth Rate (2016-2021)
Figure EU Neurological Biomarkers Revenue and Growth Rate (2016-2021)
Figure Japan Neurological Biomarkers Revenue and Growth Rate (2016-2021)
Figure China Neurological Biomarkers Revenue and Growth Rate (2016-2021)
Figure India Neurological Biomarkers Revenue and Growth Rate (2016-2021)
Figure Southeast Asia Neurological Biomarkers Revenue and Growth Rate (2016-2021)
Table Global Neurological Biomarkers Market Size by Type (2016-2021)
Figure Global Neurological Biomarkers Market Size Share by Type in 2017
Figure Global Neurological Biomarkers Market Size Share by Type in 2021
Table Global Neurological Biomarkers Market Size by Application (2016-2021)
Figure Global Neurological Biomarkers Market Size by Application in 2017
Figure Global Neurological Biomarkers Market Size by Application in 2021